We are delighted to welcome two new members to the Bionics Institute Board of Directors, Sean Moore and Paul Lefebvre.
Sean and Paul bring additional expertise to the Board, enhancing its strengths in areas such as risk mitigation, talent acquisition, and international business strategy.
Chair of the Board, Mr John Stanhope welcomes the announcement, saying: “The Bionics Institute will greatly benefit from the extensive expertise of our new Board Directors. We look forward to collaborating with them to further strengthen the Bionics Institute’s reputation as a global leader in medical device development.”
Learn more about our new directors:
Paul Lefebvre
Paul Lefebvre has over 30 years’ experience as a human resources practitioner and leader across sectors that include financial services, pharmaceuticals, manufacturing, higher education and medical research. Presently, he is a Partner with Davidson Search and Advisory specialising in executive recruitment and business advisory services.
Paul has had significant experience in executive level management, with appointments including Human Resources Director for the faculty of Medicine Dentistry and Health Sciences at the University of Melbourne, Vice President People and Culture at Victoria University and Head of Human Resources at GlaxoSmithKline Australia for their Global Manufacturing and Supply operations.
He also led the human resources merger integration for Glaxo Wellcome Australia with SmithKline Beecham when both companies merged in 2000.
Additionally, Paul has contributed his HR and leadership expertise as a member of the People and Culture Board Committee at the Bionics Institute since 2021.
Paul says: “I am delighted to join the Board of the Bionics Institute and continue my association with the Bionics Instutute following my membership of the People and Culture Committee since 2021. I look forward to supporting my Board colleagues and our Management teams to enable our great people at the Institute to do their best work.”
Sean Moore
Sean Moore is a Partner at Deloitte, the world’s largest professional services firm built on more than 175 years’ service to clients in more than 150 countries and territories.
At Deloitte, Sean advises leading financial institutions on risk, technology and business transformation.
Prior to Deloitte, he was a Managing Director leading global investment banks Nomura and Lehman Brothers. His international career has seen him live and work in Australia, New York, London, Zurich, Frankfurt, Singapore and Hong Kong.
Sean has been supporting the Bionics Institute as a member of the Fundraising Committee through 2024.
On joining the Board, Sean said,“It’s a privilege to serve on Board of the Bionics Institute. I was drawn by their world class research, development and innovation. The multidisciplinary approach that brings together scientists, engineers and researchers is unique. I’m inspired by the collaborative approach to transforming people’s lives.”
